- Home
- ZLAB vs KAR Comparison
ZLAB vs KAR Comparison
Compare ZLAB & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- KAR
- Stock Information
- Founded
- ZLAB 2013
- KAR 2006
- Country
- ZLAB China
- KAR United States
- Employees
- ZLAB N/A
- KAR N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- KAR Retail-Auto Dealers and Gas Stations
- Sector
- ZLAB Health Care
- KAR Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- KAR Nasdaq
- Market Cap
- ZLAB 1.8B
- KAR 1.9B
- IPO Year
- ZLAB 2017
- KAR 2009
- Fundamental
- Price
- ZLAB $26.36
- KAR $16.32
- Analyst Decision
- ZLAB Strong Buy
- KAR Buy
- Analyst Count
- ZLAB 5
- KAR 5
- Target Price
- ZLAB $56.21
- KAR $20.20
- AVG Volume (30 Days)
- ZLAB 768.6K
- KAR 544.8K
- Earning Date
- ZLAB 11-12-2024
- KAR 11-06-2024
- Dividend Yield
- ZLAB N/A
- KAR N/A
- EPS Growth
- ZLAB N/A
- KAR N/A
- EPS
- ZLAB N/A
- KAR 0.09
- Revenue
- ZLAB $322,711,000.00
- KAR $1,655,700,000.00
- Revenue This Year
- ZLAB $48.34
- KAR $4.07
- Revenue Next Year
- ZLAB $47.12
- KAR $5.26
- P/E Ratio
- ZLAB N/A
- KAR $189.67
- Revenue Growth
- ZLAB 28.16
- KAR 3.27
- 52 Week Low
- ZLAB $13.48
- KAR $12.86
- 52 Week High
- ZLAB $31.22
- KAR $18.73
- Technical
- Relative Strength Index (RSI)
- ZLAB 66.11
- KAR 50.51
- Support Level
- ZLAB $23.96
- KAR $15.44
- Resistance Level
- ZLAB $27.37
- KAR $15.91
- Average True Range (ATR)
- ZLAB 1.26
- KAR 0.30
- MACD
- ZLAB -0.03
- KAR 0.03
- Stochastic Oscillator
- ZLAB 72.56
- KAR 59.86
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.